Written by Joshua Murdock, PharmD | Reviewed by Alyssa Billingsley, PharmD Published on March 17, 2022 Key takeaways: In March 2022, the FDA approved Adlarity (donepezil transdermal system) to treat Alzheimer’s-related dementia. Adlarity is a once-weekly patch that’s applied to your skin. Patches are often helpful if you can’t swallow pills or if pills cause...
